Ultrasensitive detection of circulating tumor DNA can improve clinical outcomes in aggressive B ... cell lymphoma, hurdles that include availability and cost remain to its widespread implementation.

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

Hodgkin lymphoma (formerly ... to target and destroy cancer cells and keep them from growing. Your doctor may use radiation therapy to either attempt to cure the cancer or to help treat symptoms ...

Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma. Dr. David A. Braun sat down for an interview with CURE® to ...

Chimeric antigen receptor T-cell therapy (CAR-T) has been widely applied in the clinical practice of relapse/refractory (R/R) diffuse large B-cell lymphoma (DLBCL ... and controlled well with a very ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The WU-KONG1 Part B study showed a 53.3% objective response rate and 57% ... sunvozertinib for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ...

The cancer changes the growth and development of leukocytes (white blood cells), and the ... more common in one type of lymphoma than in some leukemias, and vice versa. People with lymphomas may have ...

Here, we present a case of neoplastic SBO secondary to leiomyosarcoma in a patient with known mature B cell lymphoma. This case highlights the importance of avoiding early diagnostic closure and ...

2 To date, for many autoimmune diseases, there is no definitive cure available and new treatment options are needed. Although CAR T cell therapy for B cell-driven refractory autoimmune diseases is ...